临床药师参与1例艾滋病合并乳腺癌患者的抗肿瘤治疗与药学监护

Participation of clinical pharmacists in the anti-tumor treatment and pharmaceutical care for breast cancerin women with HIV/AIDS

摘要:

摘要：目的： 为艾滋病合并乳腺癌患者的治疗建立完整的药学监护体系。 方法： 临床药师通过参加查房、审核医嘱了解病人病情，通过查阅文献对患者抗肿瘤治疗药物剂量优化，根据文献资料调整患者的抗HIV病毒方案并开展药学监护。 结果：临床药师配合医师密切开展药学监护，患者得到了有效的抗HIV病毒和抗肿瘤治疗，治疗期间毒副反应小，顺利完成了全部疗程抗肿瘤治疗，病情得到缓解。 结论： 艾滋病合并肿瘤的药学监护体系包括制订合理的抗肿瘤方案、抗病毒方案，根据药物相互作用调整治疗方案以及尽早预防机会性感染等。临床药师在治疗过程中可以通过为患者开展药学监护，改善患者治疗结局。

Abstract:

Abstract： Objective To establish a comprehensive pharmaceutical care system for the treatment of HIV/AIDS patients with breast cancer, aiming to enhance the patients therapeutic outcomes. Methods Clinical pharmacists engaged actively in patients’ treatment by participating in ward rounds and reviewing medical orders. They determine the dose of antitumor drugs and adjusted anti-HIV treatment plans based on literature records, and carry out pharmaceutical care. Results Clinical pharmacists cooperate with physicians in pharmaceutical care. Patients receive effective anti-viral and anti-tumor treatment with minimal adverse reactions. The entire course is successfully completed, and the patients experience relief of symptoms. Conclusion The pharmaceutical care system for AIDS patients with tumors encompasses the formulation of a rational anti-tumor plan, an anti-virus strategy, adjustment of treatment plans in response to drug interactions, and prompt prevention of opportunistic infections. Clincial pharmacists, through pharmaceutical care, contribute to improve the outcomes of the patient treatment.